Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector
|
|
- Branden Barton
- 8 years ago
- Views:
Transcription
1 Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1
2 Summary The Dutch market for the pharmaceutical and medical technology sector is in great flux. Throughout modern history the pharmaceutical and medical technology sector has been innovating in the area of product development. Yet, from a business innovation perspective, even more opportunities for value creation are now available. Fueled by health care trends such as the use of social media, new openings exist for innovative solutions. This brochure provides insight into the opportunities for value creation, as well as how they may be mobilized locally in the Dutch market. This brochure is written primarily for general, commercial, marketing and corporate affairs managers in the pharmaceutical and medical technology sector. It may also serve to inspire innovative health care industry entrepreneurs to create new value in the health care supply chain. 2
3 Need The need for innovation as a priority in the pharmaceutical and medical technology sector remains consistently high. The Bridge business innovators researched the market most recently in 2010: in nearly 81% of the companies, the subject of innovation was given high or highest priority. The pharmaceutical and medical technology sector is in a complete state of flux: hospital-at-home care, the effects of the preference policy, the diminishing influence of medical sales representatives, and the rise of new revenue models in health care are all examples of the changes currently taking place in the market. The sector realizes that the changes are creating opportunities for growth. As a result, the sector is embracing the changes, which are leading to business innovations within the industries. By business innovation we mean the creation and profitable use of the new. It is a skill and an art to transform change into growth for the business. In this publication we will describe several significant trends and developments. These trends create opportunities. The opportunities are filtered through a business innovation lens. This business innovation lens includes twelve ways to innovate and create new value. Fred Nijland Annemarie van Hoogstraten Nanning de Jong The Bridge business innovators 3
4 Landscape The sector in the Netherlands is made up of over 120 pharmaceutical companies (some 30 of which are members of the trade association Nefarma), tens of wholesale businesses (four of which are major players), over 1,900 pharmacies (the great majority of which are joined into five retail franchises and chains), and about a hundred companies that supply medical technology, including a dozen major players. Mainly through a wholesaler, pharmaceutical companies supply their products and services to pharmacies (which dispense them) and to general practitioners (who prescribe them) and to health care insurers (who pay for them). The latter three parties together organize the care for the end user: patients. This complex triangular relationship is illustrated in the figure below. Medical technology companies supply health care institutions and specialists, and in this way contributing to organizing patient care. Focus Pharmaceutical company Insurer Medical technology companies Health care institutions (management and DMU) Medical specialist Wholesaler Pharmacy End user/patient Doctor Figure 1. Players in the health care industry, with the focus on the pharmaceutical and medical technology sector In this publication we will focus solely on the businesses shown in blue in Figure 1: pharmaceutical companies, wholesalers, pharmacies and medical technology companies. 4
5 The summary below lists a random sampling of some of these businesses. Pharmaceutical Wholesalers Pharmacy chains / franchises Medical technologies GlaxoSmithKline Abbott Astellas Pharma AstraZeneca Bayer Boehringer Ingelheim Janssen Cilag Lilly Nederland MSD Pfizer Roche Nederland Sanofi-Aventis and various others Mediq Brocacef Alliance Healthcare Mosadex and various others Mediq Kring Escura and various others Philips Healthcare Siemens Healthcare GE Healthcare Toshiba Medical Systems Johnson & Johnson and various others The pharmaceutical players (pharmaceutical companies, wholesalers and pharmacies) are the largest suppliers to the health care sector: in 2008 they realized sales of approximately 2.8 billion. The second largest supplier is the building sector. And in seventh place are the suppliers of medical technology. Table 1. Company names in the pharmaceutical and medical technology sector 5
6 Trends and developments Local opportunities are often created from market trends and developments. Several significant market shifts are listed below. Health care services are becoming more long-term The key to the huge advances made in cures over the past twenty years, such as those in the field of cardiovascular disease, has been innovation not only in medication but in the treatment approach and in patient lifestyle changes. Long-term care requires a close interplay between medications, therapeutic treatment, and the patient s behavior and environment. Medications give way to care solutions, with the chemical component being just one part. Geriatric diseases require a combination of solutions Aging is social gain, but it is also a challenge for the future. For example, the demand in health care is shifting towards more chronic diseases and maladies of aging, which often come in combinations. This requires integrated combinations of therapies, diet, lifestyle and medications. That, in turn, makes health care products complex propositions. To an increasing extent, the power that can be realized by the supply sector depends on these propositions, rather than on the products. Health care solutions and cost reduction are the driving forces behind new forms of cooperation In a variety of ways, care is being brought closer to the consumer. New partnerships and new care groups are being created, partly due to the enforcement of cost reduction. For the time being the emphasis is on cost reduction, but the trend is towards value creation for the patient, health care provider and payer. Innovation involving cooperation is becoming increasingly important. Pressure on margins and costs leads to new revenue models The introduction of the preference policy and hospital-to-home care, among other things, has led to a major decrease in margins. The search for new revenue models and revenue streams has begun. Value creation takes shape at the level of the medical condition It is not the hospital that is relevant to the patient, but the quality of the entire treatment approach, involving multidisciplinary chains of cooperation. There are already intermediaries working on transparency to guide patients 6
7 to the best chain. There are health care alliances and innovative cooperative relationships centered around a single medical condition. The winners have a unique business model, which will be tough to copy. Pharmaceutical and equipment innovation become life sciences innovations In (foreign) R&D centers, spectacular progress is being made in the fields of nutrition, health and sustainability. In addition, fields such as diagnostics, medicines and medical devices (such as stents in blood vessels) overlap each other to an increasing extent. This leads to complex life sciences solutions that need to be brought to the market in the Netherlands and be implemented by the Dutch players in health care. Such product introductions are consequently much more complicated than they used to be. Price becomes cost-for-the-insurer The price of medication is being replaced by the concept of cost-for-theinsurer. The costs of the entire treatment over the full treatment period (which can even be a lifetime, for chronic patients) are crucial. Together with other players in the health care industry, the pharmaceutical and medical technology sector will arrive at new costs and business models to make this possible. The consumer/patient is changing, taking more initiative To an ever increasing extent, patients are becoming active in their use of social media and the internet after receiving a doctor s diagnosis. They gather information, form opinions and express themselves. It is becoming essential for health care providers, pharmaceutical companies and medical technology providers to respond to this trend. This raises many problems in terms of regulation, but also offers many possibilities. The influence of medical sales representatives and account managers on those who make health care decisions is decreasing Medical sales representatives have an average of less than 15 minutes to spend with doctors. Providing accurate information on medications has never been so difficult. Contact with the people in institutions who formulate policy on revenue models and health care strategies is limited. And things are no better with regard to the dialog needed for co-creation (between those making the decisions in an institution and the supplying industries). 7
8 Business innovation lens: opportunities for growth in the sector The industry trends can lead to countless business innovations. New value will be created, allowing sales revenue to grow. Businesses can also grow in their customer performance (towards the patients, the doctors, hospitals and health care insurers). Plenty of opportunities! The business innovation lens (Figure 2) is used for translating trends into business innovation opportunities. Companies can innovate along several axes, such as the revenue models axis. These innovations may be incremental (the inner ring) or radical (the outermost ring). The ring between them indicates that it entails a substantial innovation. Later in this publication we use this model to channel the opportunities described into a stepby-step plan, which the companies in the sector can apply to turn the innovations into growth. Health care knowledge Health care products 3. Health care services Health care alliances and partnerships 2. Health care marketing concepts What Health care channels Where Who 0. Health care customers How Care supply chain 1. Health care experiences 6. Health care organization 5. Commercial processes 4. Health care revenue model Figure 2. Business innovation opportunities for the sector 8
9 By looking along the different axes, we see various opportunities emerging. The sector creates new sales opportunities by starting with patients and doctors experience of care (1): how do they feel about the care? Both at the level of deeds and on an emotional level? A deep dive into the life and work of patients, doctors and hospitals reveals prospects for innovation, which in turn lead to health care marketing concepts (2) and services (3). Together these form the foundation for finding new revenue models (4), new commercial processes (5) and improved organization of care and partnerships (6). This connecting thread ensures new collaborations (with health care insurers and various other parties) and channels. Many companies in this sector are still working according to the old marketing model, characterized by product-oriented thinking based on the four P s (product, place, price, promotion) as the marketing mix. The old four P s have now been replaced by the four C s, in which everything revolves around customer value: 1. The product becomes the customer solution - Where can you add value in the customer process? 2. The price becomes cost-for-the-insurer - It is not the price of the medication that is important, but the effect it has on the cure. 3. The place becomes convenience ease and closeness to the patient (as in hospital-at-home care) 4. The promotion becomes communication interaction with customers, doctors and the decision making units of health care institutions and insurers. Many companies in the sector are lacking a consistent strategy and plan for serving this new market reality effectively. The emphasis is still on medications, and it needs to shift to value creation through treatment channels. Gearing the value creation to health insurers is cumbersome. There are plenty of ideas in the sector, but few successful implementations. 9
10 Specific approaches for the Dutch market The business innovation opportunities above will inspire the companies in the sector to take steps. We see the following steps clearly before us: STEP 1. Get a sense of how patients and doctors experience health care, through patient & doctor journeys that answer the question of how care is experienced. A deep dive into the life and work of the patient, doctor and hospital reveals prospects for innovation, which in turn lead to health care marketing concepts and services. STEP 2. Health care concept development Based on patients and doctors experiences of health care, we can formulate concepts and an appropriate business model in which the basis for an approach to care that creates new value is made up of not only medications, but of services, processes, ICT care protocols, etc. The lead time of pharmaceutical innovation projects is often long. Accelerating time-to-market is necessary. 10
11 STEP 3. The innovation growth strategy Many pharmaceutical companies struggle with falling margins, and sometimes also with falling sales revenue. In the Netherlands, the new developments must be anchored locally in a coherent growth and organizational strategy covering the four C s (customer value through Customer solutions, Cost-for-theinsurer, Convenience and Communication). Figure 3. Business Model Generation, by Osterwalder & Pigneur STEP 4. The development of revenue models A revenue model describes the way a business earns money and incurs expenses, and how it thus creates value for its owners and stakeholders. Boundaries must be set up to facilitate investments and streamline decisions on licensing and partnerships. With a revenue model approach, concepts are developed into commercially attainable initiatives. 11
12 STEP 5. Commercial innovation services will ensure that businesses can pass on the value of new services to the doctors, care groups and insurers, as well. Without this step, the creation of the new would not become profitable use of the new. Medical sales representatives will be retrained as health care innovators who must actualize the new value in the health care spectrum (in the form of higher sales/margin). STEP 6. The execution and realization with project management in the health care organizations ensure that the new developments are aligned with people s roles and jobs and with the processes. Market introduction methods and commercial processes must be changed significantly to meet the new reality, to be geared more towards the personnel, the processes and the technology. Effective change management is a necessity. 12
13 STEP 7. ICT-based innovations and supply chain realization: The new approach and organization lead to an integrated use of new technologies such as social media and mobile apps for the ipad. These become innovative applications for doctors and patients, supporting the treatment methods. In logistics, consider technological developments such as central filling. STEP 8. Innovating through collaboration: In the future health care innovations will take place solely in the multidisciplinary health care supply chain, requiring collaboration. Collaboration is a skill and an attitude, which has not been developed evenly throughout the health care sector and still presents plenty of opportunities! 13
14 Who are we? The Bridge business innovators help industries like the pharmaceutical and medical technology sector to innovate and achieve new sales revenue. As advisor and manager, The Bridge creates bridges between existing and new business, between technology and marketing, and achieves results. We are a subsidiary of Twynstra Gudde and a partner in Highland Worldwide. We have worked for many organizations internationally, including those listed on the following page. Highland Worldwide is a strategic alliance between consultancy firms in Europe, USA, China, Japan, Singapore, Australia, Brazil and United Arab Emirates (51 offices in total). The expertise of over 2,200 consultants and managers gives us a solid basis to assist you with local support. 14
15 In the pharmaceutical and medical technology sector, we focus on the following areas: 1. Creating road maps of patients and doctors health care experience: The Bridge provides patient & doctor journeys. 2. Developing concepts and accelerating project innovation: The Bridge provides health care concept development and project management. 3. Anchoring new developments in growth and organizational strategies for pharmaceutical companies: The Bridge provides consulting services for innovation and revenue growth strategies. 4. Developing scenarios and new revenue models: The Bridge offers workshops on revenue models in the medical sector. 5. Producing commercial success: The Bridge gives your management commercial impact, and achieves product launch goals. 6. Aligning new developments with the roles, jobs and processes: The Bridge provides innovation delivery and change management. 7. Using new technologies (such as social media and ipad technology): The Bridge provides Healthcare E-business support. 8. Innovating through working together in the health care supply chain: The Bridge provides venture team programs. 15
16 The Bridge business innovators Address: Phone: Website: Stationsplein 1 P. O. Box AX Amersfoort The Netherlands frednijland@thebridge.nl
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
More informationHealthcare, Regulatory and Reimbursement Landscape - Australia
Brochure More information from http://www.researchandmarkets.com/reports/2207850/ Healthcare, Regulatory and Reimbursement Landscape - Australia Description: Healthcare, Regulatory and Reimbursement Landscape
More informationThe Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals
The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical
More informationAll available Global Online MBA routes have a set of core modules required to be completed in order to achieve an MBA. Those modules are:
All available Global Online MBA routes have a set of core modules required to be completed in order to achieve an MBA. Those modules are: Management and Organizational Change (P.4) Leading Strategic Decision
More informationPharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
More informationHealthcare Challenges and Trends The Patient at the Heart of Care
WHITE PAPER Healthcare Challenges and Trends The Patient at the Heart of Care Quality healthcare is one of the most important factors in how individuals perceive their quality of life. In most countries,
More informationAll available Global Online MBA routes have a set of core modules required to be completed in order to achieve an MBA.
All available Global Online MBA routes have a set of core modules required to be completed in order to achieve an MBA. Those modules are: Building High Performance Organisations Management and Organisational
More informationPivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform
PRESS RELEASE Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform Pivot Park Screening Centre in Oss will play an important role in a new pan-european drug
More informationRio de Janeiro, Dec 10 th., 2015
Rio de Janeiro, Dec 10 th., 2015 Brazil & The Netherlands - 59% of Dutch import from Latin-America comes from Brazil; - 47% of Dutch total export to Latin-America goes to Brazil - The Netherlands 4 th
More informationEnterprise Mobility Orchestrator. Your Business. Always On.
Enterprise Mobility Orchestrator Your Business. Always On. Introduction Capgemini and Sogeti offer end-to-end Mobile Solutions for mobile strategy and services as your Enterprise Mobility Orchestrator.
More informationWhite Paper // Outcomes and experiences: Driving change in the pharmaceutical industry
Developed in conjunction with White Paper // Outcomes and experiences: Driving change in the pharmaceutical industry Sitecore helps pharmaceutical companies adapt in a rapidly changing global environment
More informationDigital Customer Experience
Digital Customer Experience Digital. Two steps ahead Digital. Two steps ahead Organizations are challenged to deliver a digital promise to their customers. The move to digital is led by customers who are
More informationCreating transparency as basis for Supply Chain improvement
Creating transparency as basis for Supply Chain improvement Article by Marc van Brunschot, Consultant Supply Chain Management Maurice Uiterweerd Consultant Supply Chain Management Breda, The Netherlands
More informationValue added services of pharmaceutical fullline wholesalers. Contact GIRP for discussing partnerships + 32 2 777 99 77 girp@girp.
Value added services of pharmaceutical fullline wholesalers Contact GIRP for discussing partnerships + 32 2 777 99 77 girp@girp.org Selected examples from GIRP s integrated member companies: Please note
More informationUnderstanding the Health Care Challenge from a Market and Human Capital Acquisition Perspective
Understanding the Health Care Challenge from a Market and Human Capital Acquisition Perspective Copyright 2007 cors, Inc. 1 Understanding the Health Care Challenge from a Market and Human Capital Acquisition
More informationMSD Information Technology Global Innovation Center. Digitization and Health Information Transparency
MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology
More informationA Private Investor Guide to Regenerative Medicine: Unique Opportunities in an Emerging Field
A Private Investor Guide to Regenerative Medicine: Unique Opportunities in an Emerging Field Introduction The field of regenerative medicine remains at the forefront of personalized medicine and healthcare
More informationOutcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
More informationDiabetes Trends in the U.S.: Results from the National Health and Wellness Survey. White Paper. by Kathy Annunziata and Nikoletta Sternbach
White Paper Catalysts driving successful decisions in life sciences. Diabetes Trends in the U.S.: Results from the National Health and Wellness Survey by Kathy Annunziata and Nikoletta Sternbach January
More informationSupport across the value chain. Expertise for Offshore Renewables Projects. rpsgroup.com/downstream
Downstream Consultancy Support across the value chain Expertise for Offshore Renewables Projects rpsgroup.com/downstream 2 Downstream Consultancy RPS Energy a global energy consultancy n RPS Energy is
More informationI am not a prospect I am a partner
IntelliRx, Transforming Prospect to Partner I am not a prospect I am a partner Scalable Systems Life Science & Healthcare Practices Improve Your DNA Data, Numbers & Analytics Intelli Rx Scalable Systems
More informationS P E C I A L I S T A N D M A S T E R S T U D I E S
University Ss, Cyril and Methodius Skopje FACULTY OF PHARMACY S P E C I A L I S T A N D M A S T E R S T U D I E S Healthcare management and pharmacoeconomics Skopje, 2007 STUDY PLAN -Specialist Studies-
More informationIndustry NHS data sharing for collaborative product development
Industry NHS data sharing for collaborative product development Changing strategies in clinical evidence gathering: Are randomised, doubleblinded studies to become extinct? The RCT is not extinct, but
More informationPrivate Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS
How To Apply For IFC Financing About IFC A company or entrepreneur seeking to establish a new health project or expand an IFC, a member of the World Bank Group, is the largest global development existing
More informationWhat sets breakthrough innovators apart PwC s Global Innovation Survey 2013: US Summary
What sets breakthrough innovators apart PwC s Global Innovation Survey 2013: US Summary www.pwc.com/innovationsurvey 60% $250b The top innovators in our study plan to grow by more than 60 percent over
More informationThe Natural Step Canada s Strategic Plan 2013-2017. The Natural Step Canada Strategic Plan 2013-2017 Summary for www.naturalstep.
The Natural Step Canada Strategic Plan 2013-2017 Summary for www.naturalstep.ca 1 INTRODUCTION The Natural Step Canada is an entrepreneurial charity that delivers projects and programs based on our expertise
More informationDigital Leaders Deal With a Range of Organizational Challenges
May 22, 2014 OVERCOMING OBSTACLES TO DIGITAL TRANSFORMATION SUCCESS IN THE PHARMACEUTICAL INDUSTRY Digital Leaders Deal With a Range of Organizational Challenges by Tim van Tongeren with Dennis van Rooij
More informationwww.pwchk.com Inspiration for what is possible Inspiring new possibilities for your business with PwC and Oracle
www.pwchk.com Inspiration for what is possible Inspiring new possibilities for your business with PwC and Oracle Oracle Business Applications Practice Overview December 2013 Inspiring new possibilities
More informationMoving beyond the pill Increasing consumer engagement through retail pharmacy services
Moving beyond the pill Increasing consumer engagement through retail pharmacy services The pharmacy business is undergoing dramatic changes. Fueled by health care reform, increasing competition, and shrinking
More informationJoin our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
More informationFull Time Master of Science in Management program. Core concepts and disciplinary foundations of the courses. Marketing Management Specialization
Full Time Master of Science in program Core concepts and disciplinary foundations of the courses Specialization Courses during the adaptation phase (Pre-Master) Deep Dive Business Strategy Managerial Economics
More informationInnovative & agile business solution for suppliers
Innovative & agile business solution for suppliers Smart flexibility. Delivered. 1 UMAX - The utility solution Certified by Microsoft, delivering smart flexibility UMAX is the answer for utilities looking
More informationWHITE PAPER MARCH 2014. TechInsights Report: The Changing Role of IT and What to Do About It
WHITE PAPER MARCH 2014 TechInsights Report: The Changing Role of IT and What to Do About It 2 WHITE PAPER: THE CHANGING ROLE OF IT AND WHAT TO DO ABOUT IT ca.com Executive Summary Today s challenging and
More informationBUILDING A BRIDGE 5/5/2015. Empowering CPA s in a Digital World. CPA.com an AICPA company Empowering CPAs and Businesses for the Digital Age
BUILDING A BRIDGE to the CPA Firm of the Future. ERIK ASGEIRSSON President, Chief Executive Officer CPA.com CPA.com an AICPA company Empowering CPAs and Businesses for the Digital Age Erik Asgeirsson,
More informationRequirements for Drug Information Centres
FIP Pharmacy Information Section Requirements for Drug Information Centres Summary All countries should provide drug information services either independently or as part of a regional network. The service
More informationPatient Centricity and the Changing Landscape of Healthcare
Patient Centricity and the Changing Landscape of Healthcare Andrea Cotter Director Healthcare Marketing IBM Corporation IBM Healthcare and Life Sciences Patient Centricity and the Changing Landscape of
More informationGreat Expectations: Why Pharma Companies Can t Ignore Patient Services
Accenture Life Sciences Rethink Reshape Restructure... for better patient outcomes Great Expectations: Why Pharma Companies Can t Ignore Patient Services Accenture Research Note: Key findings from a survey
More informationKey Messages. Health Economics & Management
Key Messages Health Economics & Management General World Health Summit 2011: Today s Science Tomorrow s Agenda The World Health Summit is the annual conference held by the M8 Alliance of the Academic Health
More informationCloud Development of Medical Systems By Oleg Kruk, Embedded Research Lab Leader, DataArt
Cloud Development of Medical Systems By Oleg Kruk, Embedded Research Lab Leader, DataArt Abstract Wireless electronic medical devices have made remote medicine a reality. Disease prevention, monitoring
More informationHarnessing vital data to inform an optimal market access strategy in the UK
White paper Harnessing vital data to inform an optimal market access strategy in the UK The power of the outcomes audit Access to >61M patient lives via EHRs since 2004 Paul Sutton, BA Hons, MA (Oxon),
More informationMaster of Science in Human Nutrition and Dietetics Justification of the need for the programme Goal of the Programme
Master of Science in Human Nutrition and Dietetics Justification of the need for the programme The nutrition landscape has shifted fundamentally since 2008. The launch of Scaling-Up Nutrition (SUN) movement
More informationRemove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach
Remove Access Barriers and Maximize Product Uptake with an Integrated Hub Model Approach When it comes to supporting the clinical and marketing objectives of any pharmaceutical franchise, helping to remove
More informationOctober 2013. Is the forecast clear on your wholesale cloud strategy?
October 2013 Is the forecast clear on your wholesale cloud strategy? Introduction Over the last few years the global cloud services market has achieved the kind of double-digit growth that for most telecom
More informationTalent & Organization. Organization Change. Driving successful change to deliver improved business performance and achieve business benefits
Talent & Organization Organization Change Driving successful change to deliver improved business performance and achieve business benefits Accenture Organization Change Distinctive solutions for transformational,
More informationHOW CLOSE ARE YOU TO YOUR CUSTOMERS?
HOW CLOSE ARE YOU TO YOUR CUSTOMERS? You know what kind of people your customers are. You likely even know their names, how often they shop with you and what they ve bought recently. But can you say which
More informationCHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
More informationGlobal Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
More informationINCREASING THE PROFITABILITY OF LOGISTICS
INCREASING THE PROFITABILITY OF LOGISTICS Despite increasing revenues, only a small number of logistics services providers are seeing increased profitability. Companies that want to grow their logistics
More informationHow To Design A Cloud Based Infrastructure For Spera
SAP Cloud Infrastructure Services Guiding you through your cloud journey Leveraging the cloud for your SAP environment offers an opportunity to fundamentally transform how your organization operates. If
More informationDrug Pooling in Clinical Trial Supply Chain
Drug Pooling in Clinical Trial Supply Chain Drug pooling in clinical trial is a process where common IMPs or Non-IMPs are pooled together for similar protocols running at each site followed by pooled distribution
More informationEvolving tactical video production- Creative Studios
WHITEPAPER JUNE 2014 www.beroe-inc.com Evolving tactical video production- Creative Studios Abstract / Business Case 1. Introduction:This whitepaper help pharma clients who allocate lower budgets to their
More information2015 Global PLM Services in Discrete Manufacturing Company of the Year Award
2015 2015 Global PLM Services in Discrete Manufacturing Company of the Year Award Frost & Sullivan 1 We Accelerate Growth Background and Company Performance Industry Challenges The industrial sector experienced
More informationUsing the cloud to drive revenue in retail Fujitsu alliance with salesforce.com
Using the cloud to drive revenue in retail Fujitsu alliance with salesforce.com Why Fujitsu? Fujitsu is a large, successful company but without the attitude. We see the whole picture and put you at the
More informationAccenture Life Sciences Cloud for Commercial Services
Accenture Life Sciences Rethink Reshape Restructure...for better patient outcomes Accenture Life Sciences Cloud for Commercial Services Powered by Salesforce.com A unique set of cloud-based capabilities
More informationASL 2, An introduction
ASL 2, An introduction Machteld Meijer and Louk Peters - Introduction - Why ASL? - What is ASL? - ASL framework - What can you do with ASL? - ASL in relation to other frameworks - More Info Introduction
More information7 STEPS. for Ascending to the Top of the ERP Implementation Mountain. Reach New Heights with Apero Solutions
7 STEPS for Ascending to the Top of the ERP Implementation Mountain Reach New Heights with Apero Solutions INTRODUCTION One of the biggest missteps that organizations take before they embark on the ERP
More informationMake the Leap from ecommerce to Omni- Channel
Iaodesign/Shutterstock An ecommerce platform is the foundation for a successful Omni- Channel business model arvato Systems North America 6 East 32nd Street, New York, New York 10016 United States All
More informationA Living Document from the National League for Nursing December 2015
VISIONSERIES TRANSFORMING NURSING EDUCATION L E A D I N G T H E C A L L T O R E F O R M Interprofessional Collaboration in Education and Practice A Living Document from the National League for Nursing
More informationA Real Time Lab for Pan Canadian Innovation Leveraging Canadian Blood Services Model for Better Value to Health care Systems
A Real Time Lab for Pan Canadian Innovation Leveraging Canadian Blood Services Model for Better Value to Health care Systems November 14, 2014 Submission to the Advisory Panel on Health Care Innovation
More informationInnovative & agile business solution for integrated utilities
Innovative & agile business solution for integrated utilities Smart flexibility. Delivered. 1 UMAX - The utility solution Certified by Microsoft, delivering smart flexibility UMAX is the answer for utilities
More informationHelping pharmaceutical, life science and other healthcare companies respond to a changing environment
Helping pharmaceutical, life science and other healthcare companies respond to a changing environment Real and immediate challenges Life sciences, pharmaceutics and health care are experiencing a period
More informationHow Global Banks Are Gearing Up to Address Emerging International Payment Processing Needs
Cognizant 20-20 Insights How Global Banks Are Gearing Up to Address Emerging International Processing Needs Executive Summary Recent times have seen a significant upturn in the number of international
More informationRISK ADJUSTMENT ARRIVES FOR COMMERCIAL HEALTH INSURANCE
POINT OF VIEW RISK ADJUSTMENT ARRIVES FOR COMMERCIAL HEALTH INSURANCE HHS s risk adjustment program for the small group and individual markets will reduce some of the effects of adverse selection but it
More informationOverview of the Specialty Drug Trend
WHITE PAPER Overview of the Specialty Drug Trend Succeeding In The Rapidly Changing U.S. Specialty Market 1 Specialty drugs are prescribed to treat complex conditions such as cancer, HIV and inflammatory
More informationPower Trading and Retail System. empowering. smarter trading. across the energy value chain. Smart energy. Powering progress
Power Trading and Retail System empowering smarter trading across the energy value chain Smart energy. Powering progress In today s turbulent and increasingly complex energy markets, Atos Worldgrid PTRS
More informationWhy Your Strategy Isn t Working
Published in Business Strategy November 2011 Why Your Strategy Isn t Working By Gary Getz and Joe Lee Setting the company or business unit s strategy has always been one of the most important jobs for
More informationThe World's Top 100 Pharmaceutical Companies
Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,
More informationHow companies leverage quality and quality certifications to achieve competitive advantage
How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for
More informationHow To Deliver A Microsoft Solution
Avanade Point of View Why the delivery approach matters for IT initiatives Value-added delivery The world is changing. The combination of rising technology change and the impact of economic uncertainty
More informationEXECUTIVE MASTER IN. Increasing corporate value in today s complex digital world through reputation management and communication with stakeholders.
EXECUTIVE MASTER IN CORPORATE COMMUNICATION Increasing corporate value in today s complex digital world through reputation management and communication with stakeholders. COURSE DESCRIPTION At a Glance
More informationCUSTOMER EXPERIENCE DESIGN CUSTOMER EXPERIENCE DESIGN
02 03 FIFTH QUADRANT Established in 1998, Fifth Quadrant is a Management Consultancy and Analyst Organisation specialising in: METHODOLOGIES USED CUSTOMER EXPERIENCE STRATEGY CUSTOMER EXPERIENCE RESEARCH
More informationChallenge of FUJIFILM in Medical ICT
Challenge of FUJIFILM in Medical ICT Sep.10, 2014 FORWARD-LOOKING STATEMENTS Forward-looking statements, such as those relating to earnings forecasts and other projections contained in this material, are
More information1. Alaska, Alaska Native Tribal Health Consortium Behavioral Health Aide Training Program https://www.anthc.org/chs/behavioral/bha.
1. Alaska, Alaska Native Tribal Health Consortium Behavioral Health Aide Training Program https://www.anthc.org/chs/behavioral/bha.cfm Under the direction of the Tribal Health Directors, ANTHC used the
More informationUnderstanding the Business Value of Social Solutions in Sales
WHITE PAPER Understanding the Business Value of Social Solutions in Sales Sponsored by: SAP Vanessa Thompson April 2014 IDC OPINION The confluence of the changing competitive landscape, strategic business
More informationPharmaceutical Distribution in the US: Current and Future Perspectives
Pharmaceutical Distribution in the US: Current and Future Perspectives Publication date: July 2009 Number of pages: 83 Author: Dr Faiz Kermani Pricing: 1,495 (PDF) / 1,550 (print) "In the US, the pharmaceutical
More informationCHANGE MANAGEMENT - THE 12 STEP PROCESS. Article by Herb Rubenstein. Introduction
CHANGE MANAGEMENT - THE 12 STEP PROCESS Article by Herb Rubenstein Introduction The two chief trends currently at work in the business world, rapid development of technology and globalization, have brought
More informationCore Banking Transformation using Oracle FLEXCUBE
in collaboration with Core Banking Transformation using Oracle FLEXCUBE Unlocking the power of FLEXCUBE with Capgemini Moving towards a packaged system transformation program Capgemini is an Oracle Diamond
More informationThe Need to Embrace Profit Cycle Management in Healthcare
GE Healthcare The Need to Embrace Profit Cycle Management in Healthcare Justin Steinman General Manager GE Healthcare IT Top 5 Takeaways 1. Healthcare leaders need to start analyzing and controlling costs
More informationRx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
More informationNutraceutical Medical Research, LLC. By: Latesha Richards, Marketing Coordinator
The Value of Conducting Post-Marketing Clinical Research On Marketing Strategy Development Nutraceutical Medical Research, LLC By: Latesha Richards, Marketing Coordinator Those of us who are marketing
More informationSupplier Connect Supplier Collaboration within Product Development. December 2015
Supplier Connect Supplier Collaboration within Product Development December 2015 Supplier Connect - Supplier Collaboration within Product Development 2 Published by Atos SE - River Ouest - 80, quai Voltaire
More informationInnovation in Business Models for Start-ups. Prof. Dr. Utz Dornberger in4in Workshop Rwanda, 2014
Innovation in Business Models for Start-ups Prof. Dr. Utz Dornberger in4in Workshop Rwanda, 2014 Business idea Many existent enterprises have the goal to develop a new sui-generis product Almost every
More informationStakeholder Guide 2014 www.effectivehealthcare.ahrq.gov
Stakeholder Guide 2014 www.effectivehealthcare.ahrq.gov AHRQ Publication No. 14-EHC010-EF Replaces Publication No. 11-EHC069-EF February 2014 Effective Health Care Program Stakeholder Guide Contents Introduction...1
More informationIssues in Information Systems Volume 13, Issue 2, pp. 397-403, 2012
397 THE BENEFITS OF CUSTOMER RELATIONSHIP MANAGEMENT (CRM) IN THE HEALTHCARE INDUSTRY Chester D. Thompson, Robert Morris University, cdtst10@rmu.edu ABSTRACT The pharmaceutical industry has undergone rapid
More informationPower pricing in business current accounts:
Financial Services Banking Power pricing in business current accounts: Tomorrow s innovative model starts today Horatiu Kraus, Ben Snowman, Jens Baumgarten, Georg Wuebker 1 Introduction The UK business
More informationThis is the author s version of a work that was submitted/accepted for publication in the following source:
This is the author s version of a work that was submitted/accepted for publication in the following source: Gable, Guy (2006) The internet, globalization, and IT professional services. Journal of Global
More informationTapping the Potential: The Accenture Industrial Equipment Industry Group
Tapping the Potential: The Accenture Industrial Equipment Industry Group Industrial equipment is an industry that holds an untapped potential for growth across the globe. And that growth is fueled by
More informationRoss Career Services. Health Care. Introduction. Health Care Overview
Ross Career Services Career Path: Health Care Introduction Ross Career Services (RCS) created the Career Path series to assist students with the career search process. Each Career Path (online) handout
More informationCODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association
More informationGlobal Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
More informationHow To Sell A Breathalyzer
Akers Biosciences Announces Q2 2015 Earnings US Sales of Rapid HIT Test Continue to Rise: +67% Over Q2 2014 Conference Call Scheduled for 9:00 a.m. EDT Today THOROFARE, N.J., August 18, 2015 (GLOBE NEWSWIRE)
More informationThe Value of OTC Medicine to the United States. January 2012
The Value of OTC Medicine to the United States January 2012 Table of Contents 3 Executive Summary 5 Study Methodology 7 Study Findings 10 Sources 2 Executive Summary For millions of Americans, over-the-counter
More informationThe Ministry of Economic Affairs chairs the National Contact Point (NCP). Chairman and board: Advisory members NCP Secretariat:
National Contact Point, The Netherlands Annual Report 2008 (June 2007- May 2008) Institutional Arrangements The Ministry of Economic Affairs chairs the National Contact Point (NCP). Ministry of Economic
More informationABCD. Welcome to BICI. Petersburg, Virginia
Welcome to BICI Petersburg, Virginia Our Company Our Worldwide Company in Brief: - Focus on Human Pharmaceuticals and Animal Health - Founded 1885 in Ingelheim, Germany - Products marketed in some 150
More informationParallel Session 2 Five Pillars to succes A framework for approaching market research in Emerging Markets
Parallel Session 2 Five Pillars to succes A framework for approaching market research in Emerging Markets Steve Kretschmer, Ipsos, Turkey and Beyza Ozel, Novartis, Turkey 5 Pillars to Success: A Framework
More informationCustomizing the Cold Chain. The growing need for targeted temperature-control solutions.
Customizing the Cold Chain The growing need for targeted temperature-control solutions. Nils Markmann, Director, Global Operations Andreas Kjällander, Head of Temperature-Control Management Market summary
More informationFormulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
More informationStatement by. Joachim Schäfer, managing director of Messe Düsseldorf GmbH. on MEDICA 2015 in Düsseldorf (November 16th to the 19th)
Statement by Joachim Schäfer, managing director of Messe Düsseldorf GmbH on MEDICA 2015 in Düsseldorf (November 16th to the 19th) To get to the top is difficult;, to stay at the top is even more difficult.
More informationHow to bridge the gap between business, IT and networks
ericsson White paper Uen 284 23-3272 October 2015 How to bridge the gap between business, IT and networks APPLYING ENTERPRISE ARCHITECTURE PRINCIPLES TO ICT TRANSFORMATION A digital telco approach can
More informationRESEARCH APRIL 2014. Health & Life Sciences. AUTHORS Graegar Smith Principal. Chris Bernene Partner
Health & Life Sciences RESEARCH APRIL 2014 ARE CONSUMERS READY FOR RETAIL HEALTHCARE? A new Oliver Wyman survey finds strong interest, little familiarity, and complex preferences. The verdict for retailers,
More information